Skip to content
clinical-trial-investigator-agreement logo

Clinical Trial Investigator Agreement

clinical-trial-investigator-agreement

Drafts U.S. clinical trial Investigator Agreements between sponsors/CROs and principal investigators or institutions for FDA-regulated drug, biologic, or device studies. Enforces 21 CFR Parts 50, 56, 312/812, ICH GCP E6(R2), HIPAA, IRB requirements, FMV/AKS payment compliance, data integrity, publication rights, IP ownership, indemnity, and audit access. Use when drafting investigator agreements, PI agreements, clinical trial site agreements, or sponsor-PI contracts; trigger keywords: investigator agreement, clinical trial agreement, PI agreement, FDA, IND, IDE, IRB, GCP, clinical research agreement, site agreement.

CaseMark/skills0installs44starsMarketing

SKILL.md

Full skill instructions

Clinical Trial Investigator Agreement

Drafts a sponsor–PI/​site agreement that operationalizes FDA, IRB, and GCP obligations for a specific clinical trial.

Prerequisites

  1. Protocol number, title, version date, phase, endpoints, enrollment target.
  2. Investigator's brochure or device manual; investigational product handling requirements.
  3. Sponsor identity, CRO involvement, contracting structure (institution, PI, or both).
  4. Site legal name, state law, institutional policies, and any required template language.
  5. PI credentials, sub-investigators, study team roles.
  6. Budget and payment model (per subject, per visit, milestones); invoicing rules.
  7. IRB details, consent/​assent forms, recruitment materials, vulnerable population plan.
  8. Data ownership, publication expectations, IP posture, sample handling.
  9. Insurance positions and indemnity constraints (public entities, academic limits).

Output Structure / Process

  1. Intake — targeted questions; confirm drug/​biologic (21 CFR 312) vs device (21 CFR 812) track.
  2. Draft — follow the section order below, incorporating site-specific policies.
  3. Exhibits — attach and incorporate by reference.
  4. Verify — run compliance checks using the tables and checklist below.

Regulatory Baseline

TopicAuthority
Informed consent21 CFR Part 50; LAR, assent where required
IRB21 CFR Part 56; 45 CFR 46 when institution requires
Drugs/​Biologics21 CFR Part 312; IND obligations flow down
Devices21 CFR Part 812; IDE obligations flow down
GCPICH GCP E6(R2)
Financial disclosure21 CFR Part 54
PrivacyHIPAA and state privacy laws
Vulnerable populations45 CFR 46 Subparts B, C, D

Agreement Sections

SectionMust Include
Parties and DefinitionsSponsor, institution, PI; define Study, Protocol, Investigational Product, SAE, Confidential Information
Study DescriptionProtocol incorporated by reference; scope; single vs multi-center
Investigator ResponsibilitiesConduct per protocol; no deviations except to eliminate immediate hazard; amendment approval workflow
IRB and ApprovalsNo study activities before written IRB approval; continuing review; submissions shared with sponsor
Informed ConsentCurrent IRB-approved forms; qualified designee; no coercion; LAR and assent as applicable
Study PersonnelDelegation of authority log; training documentation; PI retains ultimate responsibility
Investigational ProductReceipt only from sponsor; storage conditions; accountability logs; no off-protocol use; return/​destroy per sponsor
Safety ReportingAE/​SAE definitions; sponsor reporting timelines; IRB reporting for unanticipated problems
Data IntegrityALCOA+; source data verification; correction rules; EDC audit trail
Records and RetentionEssential documents per ICH GCP § 8; retention per 21 CFR 312.62(c) / 812.140(d), or longer per law/​policy
Monitoring and AccessReasonable advance notice; direct source access; HIPAA minimum necessary; corrective actions
Regulatory InspectionsNotify sponsor within 24 hours; provide FDA 483 or correspondence within 5 business days
ConfidentialityScope; permitted disclosures to IRB/​regulators; term and return/​destruction
Data and IP OwnershipSponsor owns study data and results; invention assignment; sample ownership with institutional carve-outs
PublicationsSponsor review window; patent delay; multicenter coordination; ICMJE authorship standards
Compensation and BudgetFMV/​AKS compliance; invoicing; screen fail and early withdrawal rules; startup/​closeout costs
Financial Disclosure/​COI21 CFR Part 54 disclosures; update obligations; conflict management
IndemnificationSponsor product liability indemnity; carve-outs for PI/​site negligence or noncompliance
InsuranceSponsor clinical trial liability; site professional liability; certificate requirements
Term and TerminationFor cause and convenience; subject safety wind-down; payment of earned fees
Governing Law/​DisputesState law selection; venue or negotiation/​mediation steps
ComplianceFCPA/​UK Bribery Act; export control/​OFAC; Sunshine Act reporting

Exhibits

  • Protocol and amendments
  • Budget and payment schedule
  • Study team roster and qualifications
  • Financial disclosure forms
  • Informed consent/​assent forms
  • Institutional policies incorporated by reference
  • Publication policy (if separate)

Default Timelines

Adjust to protocol/​IRB policy.

EventDefault
Sponsor notification of SAEWithin 24 hours of awareness
IRB submission of unanticipated problemsPer IRB policy, prompt reporting
Publication review by sponsor45–60 days before submission
Patent delay after reviewUp to 60–90 days

Final Checks

  • Parties and governing law match site and sponsor
  • All regulatory citations align with drug/​biologic vs device track
  • Consent and privacy requirements align with site policy
  • Payment terms are FMV and AKS compliant
  • Indemnity/​insurance reflect institutional limits
  • Every unverified citation marked [VERIFY]

Troubleshooting

IssueResolution
Unclear whether drug or device track appliesConfirm IND (21 CFR 312) vs IDE (21 CFR 812) with sponsor; combination products follow primary mode of action
Institution requires its own templateMerge sponsor terms into institutional template; flag conflicts for negotiation
Public entity cannot indemnifyCarve out sovereign immunity; shift to insurance-only model with higher certificate minimums
PI holds multiple roles (e.g., also sponsor-investigator)Apply 21 CFR 312.50–312.70 sponsor obligations in addition to investigator duties
Budget exceeds FMV benchmarksDocument FMV analysis methodology; adjust per AAMC/​PhRMA guidelines to avoid AKS risk

Guidelines

  • Apply the most stringent requirement among federal law, state law, and institutional policy.
  • No study activity before IRB approval and full execution if required by the institution.
  • Keep confidentiality and publication clauses consistent with multi-center coordination.
  • Preserve a clear audit trail for data corrections and monitoring access.
  • Flag any unclear regulatory citation with [VERIFY].

More Marketing skills

copywriting logo
Marketing

copywriting

Marketing copy for homepages, landing pages, pricing pages, and other conversion-focused web pages.

53.3K 216.1K
View
flux-2-klein logo
Marketing

flux-2-klein

Fast image generation with Flux 2 Klein, optimized for sub-second iteration and multi-reference brand styling.

52 176.2K
View

Psychological principles and mental models for understanding customer behavior and influencing marketing decisions.

53.3K 153K
View

Plan searchable and shareable content that drives traffic, builds authority, and generates leads.

53.3K 150.9K
View

Build SEO-optimized pages at scale using templates, data, and proven playbook patterns.

53.3K 140.1K
View

Brainstorm and prioritize marketing strategies tailored to your SaaS stage, budget, and goals.

53.3K 137.2K
View
ai-seo logo
Marketing

ai-seo

Optimize content for discovery, citation, and visibility across AI search platforms and LLM assistants.

53.3K 136.7K
View
copy-editing logo
Marketing

copy-editing

Systematic improvement of existing marketing copy through seven focused editing passes.

53.3K 136.4K
View

Plan and optimize your website's page hierarchy, navigation, URL structure, and internal linking.

53.3K 112.8K
View
revops logo
Marketing

revops

Design and optimize systems connecting marketing, sales, and customer success into a unified revenue engine.

53.3K 104.9K
View

Applies Anthropic's official brand colors and typography to any sort of artifact that may benefit from having Anthropic's look-and-feel. Use it when brand colors or style guidelines, visual formatting, or company design standards apply.

179.7K 100.1K
View

Convert websites into professional HyperFrames videos with guided storyboarding and brand-aligned composition.

57K 93.5K
View

Sales & marketing AI tools

KreadoAI logo
Sales & marketing

KreadoAI

Revolutionize Video Creation with AI-Generated Avatars and Voices

Paid
View
Followr logo
Sales & marketing

Followr

Social media on autopilot

Paid
View
Logodiffusion logo
Sales & marketing

Logodiffusion

Design custom logos instantly with AI.

Paid
View
I
Sales & marketing

Ideogram

Text-heavy marketing and design images

Freemium
View
Prompt Silo logo
Sales & marketing

Prompt Silo

Boost Your SEO with Content and SEO Silos

Free
View
Marketing Blocks logo
Sales & marketing

Marketing Blocks

Revolutionize Your Marketing with AI-Powered MarketingBlocks!

Paid
View
Scrip AI logo
Sales & marketing

Scrip AI

10X faster & free AI content creation for 100+ use cases

Free
View
Tribescaler logo
Sales & marketing

Tribescaler

Tribescaler | Make Your Tweets Go Viral

Paid
View